Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

NextEdge Admin

03 Feb 2025

2 min 43 sec

Union Minister Dr. Jitendra Singh inaugurated the Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu, highlighting the transformative impact of gene therapy. He emphasised that genomic advancements would enable personalised treatment approaches rather than a one-size-fits-all method, ensuring higher efficacy and specificity.

The Minister stated that gene therapy offers customised disease management, where even patients with the same condition—such as cancer or kidney disease—could receive different treatments based on their genetic profiles. Set up in collaboration with 4baseCare, the centre aims to revolutionise personalised medicine by integrating genomic research into targeted treatment strategies.

AIIMS Jammu now stands among India's leading medical research institutions, leveraging AI-driven diagnostics and genomic data for early disease detection, optimised treatment, and reduced trial-and-error in prescriptions. Experts noted that this facility would advance precision oncology, cardiovascular genomics, and genetic screening for rare disorders.

Dr. Singh highlighted India's unique genetic diversity, underscoring the need for an India-specific genomic database. He mentioned ongoing efforts that have mapped 10,000 healthy individuals across 99 communities, aiming to address country-specific health challenges. He also stressed that making precision medicine affordable is a key goal, with AIIMS Jammu working to integrate these treatments into public healthcare through indigenous research and government-backed biotech initiatives.

Precision medicine, he noted, could be a game-changer in cancer treatment, shifting from conventional chemotherapy to targeted therapies. Genomic medicine is also crucial for tackling lifestyle diseases like diabetes, which is increasingly affecting younger populations in India.

AIIMS Jammu Director Dr. Shakti Gupta praised Dr. Singh for his support, while AIIMS President Dr. YK Gupta and AIIMS New Delhi Director Dr. M. Srinivas also addressed the gathering.